Vedolizumab
Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
Product Specifications
CAS Number
943609-66-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
147 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Integrin
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog